Observed | Model A | Model B | Model C | Model D | Model E | Model F | Model G | |
---|---|---|---|---|---|---|---|---|
Indmax 8,a | Indmax 8 liver, 16 gut, | Indmax 16 | Indmax 22.7 | Indmax 29.9 | Indmax 12 | Indmax 20 | ||
IndC50 0.32a | IndC50 0.32 | IndC50 0.32 | IndC50 0.30 | IndC50 0.71 | IndC50 0.32 | IndC50 0.32 | ||
Rifampicin, i.v. MDZ | ||||||||
Geometric mean fold induction | 1.99 | 1.71 | 1.72 | 2.04 | 2.13 | 2.11 | 1.96 | 2.15 |
GMFE | 1.21 | 1.21 | 1.16 | 1.18 | 1.18 | 1.16 | 1.20 | |
RMSE | 0.51 | 0.47 | 0.36 | 0.38 | 0.38 | 0.38 | 0.40 | |
% Within acceptance limitsb | 83.3 | 100 | 100 | 83.3 | 83.3 | 100 | 83.3 | |
Rifampicin, oral MDZ | ||||||||
Geometric mean fold induction | 18.1 | 6.47 | 9.69 | 17.1 | 29.3 | 26.6 | 10.9 | 23.7 |
GMFE | 3.26 | 2.21 | 1.70 | 1.96 | 1.85 | 1.99 | 1.75 | |
RMSE | 27.0 | 24.8 | 21.6 | 21.5 | 20.7 | 24.1 | 20.6 | |
% Within acceptance limitsb | 27.3 | 45.5 | 72.7 | 36.4 | 36.4 | 63.6 | 63.6 | |
Rifampicin, all MDZ (i.v. and oral) | ||||||||
Geometric mean fold induction | n/a | |||||||
GMFE | 2.30 | 1.79 | 1.48 | 1.64 | 1.58 | 1.65 | 1.53 | |
RMSE | 21.7 | 20.0 | 17.4 | 17.3 | 16.7 | 19.4 | 16.5 | |
% Within acceptance limitsb | 47.1 | 58.8 | 82.4 | 52.9 | 52.9 | 76.5 | 70.6 | |
Rifampicin, all victims (i.v.) | ||||||||
Geometric mean fold induction | n/a | |||||||
GMFE | 1.24 | 1.24 | 1.15 | 1.16 | 1.13 | 1.16 | 1.17 | |
RMSE | 0.53 | 0.56 | 0.35 | 0.36 | 0.35 | 0.42 | 0.37 | |
% Within acceptance limitsb | 90.0 | 100 | 100 | 90.0 | 90.0 | 100 | 90.0 | |
Rifampicin, all victims (oral) | ||||||||
Geometric mean fold induction | n/a | |||||||
GMFE | 2.81 | 2.12 | 1.69 | 1.91 | 1.80 | 1.96 | 1.72 | |
RMSE | 21.5 | 19.9 | 17.7 | 20.5 | 19.2 | 19.1 | 18.9 | |
% Within acceptance limitsb | 26.3 | 26.3 | 68.4 | 52.6 | 52.6 | 73.7 | 68.4 | |
Rifampicin, all victim drugs | ||||||||
Geometric mean fold induction | n/a | |||||||
GMFE | 2.12 | 1.77 | 1.48 | 1.61 | 1.53 | 1.63 | 1.51 | |
RMSE | 17.4 | 16.1 | 14.4 | 16.5 | 15.5 | 15.5 | 15.3 | |
% Within acceptance limitsb | 48.3 | 51.7 | 79.3 | 65.5 | 65.5 | 79.3 | 75.9 |
GMFE, geometric mean fold error; n/a, not applicable; RMSE, root mean square error.
↵a Default rifampicin induction parameters (V12). Geometric mean fold induction for observed data were calculated in a meta-analysis using published methodology (Einolf, 2007; Cubitt et al., 2011; Ghobadi et al., 2011; Barter et al., 2013; Supplemental Table 3).
↵b Acceptance limits proposed by Guest et al. (2011).